Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Parthasarathy Satishchandra is active.

Publication


Featured researches published by Parthasarathy Satishchandra.


Nature | 2014

A draft map of the human proteome

Min Sik Kim; Sneha M. Pinto; Derese Getnet; Raja Sekhar Nirujogi; Srikanth S. Manda; Raghothama Chaerkady; Dhanashree S. Kelkar; Ruth Isserlin; Shobhit Jain; Joji Kurian Thomas; Babylakshmi Muthusamy; Pamela Leal-Rojas; Praveen Kumar; Nandini A. Sahasrabuddhe; Lavanya Balakrishnan; Jayshree Advani; Bijesh George; Santosh Renuse; Lakshmi Dhevi N. Selvan; Arun H. Patil; Vishalakshi Nanjappa; Aneesha Radhakrishnan; Samarjeet Prasad; Tejaswini Subbannayya; Rajesh Raju; Manish Kumar; Sreelakshmi K. Sreenivasamurthy; Arivusudar Marimuthu; Gajanan Sathe; Sandip Chavan

The availability of human genome sequence has transformed biomedical research over the past decade. However, an equivalent map for the human proteome with direct measurements of proteins and peptides does not exist yet. Here we present a draft map of the human proteome using high-resolution Fourier-transform mass spectrometry. In-depth proteomic profiling of 30 histologically normal human samples, including 17 adult tissues, 7 fetal tissues and 6 purified primary haematopoietic cells, resulted in identification of proteins encoded by 17,294 genes accounting for approximately 84% of the total annotated protein-coding genes in humans. A unique and comprehensive strategy for proteogenomic analysis enabled us to discover a number of novel protein-coding regions, which includes translated pseudogenes, non-coding RNAs and upstream open reading frames. This large human proteome catalogue (available as an interactive web-based resource at http://www.humanproteomemap.org) will complement available human genome and transcriptome data to accelerate biomedical research in health and disease.


Journal of Virology | 2004

Tat Protein of Human Immunodeficiency Virus Type 1 Subtype C Strains Is a Defective Chemokine

Udaykumar Ranga; Raj Shankarappa; Nagadenahalli B. Siddappa; Lakshmi Ramakrishna; Ramalingam Nagendran; Marthandan Mahalingam; Anita Mahadevan; Narayana Jayasuryan; Parthasarathy Satishchandra; Susarla K. Shankar; Vinayaka R. Prasad

ABSTRACT Human immunodeficiency virus type 1 (HIV-1)-associated dementia (HAD) is correlated with increased monocyte migration to the brain, and the incidence of HAD among otherwise asymptomatic subjects appears to be lower in India than in the United States and Europe (1 to 2% versus 15 to 30%). Because of the genetic differences between HIV-1 strains circulating in these regions, we sought to identify viral determinants associated with this difference. We targeted Tat protein for these studies in view of its association with monocyte chemotactic function. Analyses of Tat sequences representing nine subtypes revealed that at least six amino acid residues are differentially conserved in subtype C Tat (C-Tat). Of these, cysteine (at position 31) was highly (>99%) conserved in non-subtype C viruses and more than 90% of subtype C viruses encoded a serine. We hypothesized a compromised chemotactic function of C-Tat due to the disruption of CC motif and tested it with the wild type C-Tat (CS) and its two isogenic variants (CC and SC) derived by site-directed mutagenesis. We found that the CS natural variant was defective for monocyte chemotactic activity without a loss in the transactivation property. While the CC mutant is functionally competent for both the functions, in contrast, the SC mutant was defective in both. Therefore, the loss of the C-Tat chemotactic property may underlie the reduced incidence of HAD; although not presenting conclusive evidence, this study provides the first evidence for a potential epidemiologic phenomenon associated with biological differences in the subtype C viruses.


Journal of NeuroVirology | 2007

Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India

Jayashree Das Gupta; Parthasarathy Satishchandra; Kumarpillai Gopukumar; Frances L. Wilkie; Drenna Waldrop-Valverde; Ronald J. Ellis; Raymond L. Ownby; D. K. Subbakrishna; Anita Desai; Anupa Kamat; V. Ravi; B. S. Rao; Kadappa Shivappa Satish; Mahendra Kumar

Most studies of cognitive functioning in human immunodeficiency virus type 1 (HIV-1)-seropositive (HIV-1+) subjects have been done in the United States and Europe, where clade B infections predominate. However, in other parts of the world such as South India, where clade C HIV is most common, the prevalence of HIV-1 is increasing. Standardized neuropsychological tests were used to assess cognitive functioning in a sample of 119 adults infected with clade C HIV-1 who were not on antiretroviral medications. The subjects did not have neurological or psychiatric illness and were functioning adequately. Neuropsychological test performance was compared with gender-, age-, and education-matched normative data derived from a sample of 540 healthy volunteers and a matched cohort of 126 healthy, HIV-1-seronegative individuals. Among the seropositive subjects, 60.5% had mild to moderate cognitive deficits characterized by deficits in the domains of fluency, working memory, and learning and memory. None of the subjects had severe cognitive deficits. The HIV-1+ sample was classified into groups according to the level of immune suppression as defined by CD4 count (<200, 201–499, and >500 cells/mm3) and viral load (<5000, 5001–30,000, 30,001–99,999, 100,000–1,000,000, and >1,000,001 copies). Although the most immunosuppressed group (CD4 count <200 cells/mm3 or viral load >1,000,001 copies) was small, their rate of impairment in visual working memory was greater when compared to groups with better immune functioning. Mild to moderate cognitive deficits can be identified on standardized neuropsychological tests in clade C-infected HIV-1+ adults who do not have any clinically identifiable functional impairment. The prevalence of cognitive deficits is similar to that reported in antiretroviral treatment-naïve individuals infected with clade B virus in the western world.


Epilepsia | 2003

Hot-water epilepsy.

Parthasarathy Satishchandra

Summary: Geographically specific epilepsy syndromes are of epidemiologic interest and may assist in understanding the pathogenic mechanism of epilepsy in general. Some may have a genetic basis with added environmental influence. Among these epilepsy syndromes in India is an interesting type of reflex seizure known as hot‐water epilepsy (HWE) and single small computed tomography (CT)‐enhancing lesions (SSCTLs).


Epilepsia | 1988

Hot-water epilepsy: a variant of reflex epilepsy in southern India.

Parthasarathy Satishchandra; A. Shivaramakrishana; V. G. Kaliaperumal; Bruce S. Schoenberg

Summary: “Hot water epilepsy” (HWE). precipitated by a bath or shower in hot water, has been described infrequently in the literature. We report 279 cases of HWE that were seen between 1980 to 1983 in Bangalore, South India. We found HWE to be more common in children, with cases more frequent among male than female patients (2.6:1). Complex partial seizures constituted the main clinical presentation (67.0%); HWE accounted for 4.4% of all complex partial seizures and generalized tonic‐clonic seizures seen at our center during the 1980–1983 period. Although prognosis seems favorable, 25.4% of our patients developed nonreflex epilepsy within 1–3 years. They were managed with antiepileptic drugs and the use of lukewarm water for bathing.


Journal of Clinical Microbiology | 2004

Identification of Subtype C Human Immunodeficiency Virus Type 1 by Subtype-Specific PCR and Its Use in the Characterization of Viruses Circulating in the Southern Parts of India

Nagadenahalli B. Siddappa; Prashanta Kumar Dash; Anita Mahadevan; Narayana Jayasuryan; Fen Hu; Bethany Dice; Randy Keefe; Kadappa Shivappa Satish; Bhuthiah Satish; Kuttan Sreekanthan; Ramdas Chatterjee; Kandala Venu; Parthasarathy Satishchandra; V. Ravi; Susarla K. Shankar; Raj Shankarappa; Udaykumar Ranga

ABSTRACT Human immunodeficiency virus type 1 (HIV-1) subtype C viruses are associated with nearly half of worldwide HIV-1 infections and are most predominant in India and the southern and eastern parts of Africa. Earlier reports from India identified the preponderance of subtype C and a small proportion of subtype A viruses. Subsequent reports identifying multiple subtypes suggest new introductions and/or their detection due to extended screening. The southern parts of India constitute emerging areas of the epidemic, but it is not known whether HIV-1 infection in these areas is associated with subtype C viruses or is due to the potential new introduction of non-subtype C viruses. Here, we describe the development of a specific and sensitive PCR-based strategy to identify subtype C-viruses (C-PCR). The strategy is based on amplifying a region encompassing a long terminal repeat and gag in the first round, followed by two sets of nested primers; one amplifies multiple subtypes, while the other is specific to subtype C. The common HIV and subtype C-specific fragments are distinguishable by length differences in agarose gels and by the difference in the numbers of NF-κB sites encoded in the subtype C-specific fragment. We implemented this method to screen 256 HIV-1-infected individuals from 35 towns and cities in four states in the south and a city in the east. With the exception of single samples of subtypes A and B and a B/C recombinant, we found all to be infected with subtype C viruses, and the subtype assignments were confirmed in a subset by using heteroduplex mobility assays and phylogenetic analysis of sequences. We propose the use of C-PCR to facilitate rapid molecular epidemiologic characterization to aid vaccine and therapeutic strategies.


Epilepsia | 2007

A multicenter study of BRD2 as a risk factor for juvenile myoclonic epilepsy.

Gianpiero L. Cavalleri; Nicole M. Walley; Nicole Soranzo; John C. Mulley; Colin P. Doherty; Ashish Kapoor; Chantal Depondt; John Lynch; Ingrid E. Scheffer; Armin Heils; Anne Gehrmann; Peter Kinirons; S Gandhi; Parthasarathy Satishchandra; Nicholas W. Wood; Anuranjan Anand; Thomas Sander; Samuel F. Berkovic; Norman Delanty; David B. Goldstein; Sanjay M. Sisodiya

Summary:  Purpose: Although complex idiopathic generalized epilepsies (IGEs) are recognized to have a significant genetic component, as yet there are no known common susceptibility variants. It has recently been suggested that variation in the BRD2 gene confers increased risk of juvenile myoclonic epilepsy (JME), which accounts for around a quarter of all IGE. Here we examine the association between the candidate causal SNP (the promoter variant rs3918149) and JME in five independent cohorts comprising in total 531 JME cases and 1,390 healthy controls.


Annals of Neurology | 2008

An idiopathic epilepsy syndrome linked to 3q13.3-q21 and missense mutations in the extracellular calcium sensing receptor gene

Ashish Kapoor; Parthasarathy Satishchandra; Rinki Ratnapriya; Ramesh Reddy; Jayaram S. Kadandale; Susarla K. Shankar; Anuranjan Anand

To identify the disease locus in a three‐generation south Indian family having several of its members affected with idiopathic epilepsy.


Human Molecular Genetics | 2010

Sequestration of chaperones and proteasome into Lafora bodies and proteasomal dysfunction induced by Lafora disease-associated mutations of malin

Sudheendra N. R. Rao; Ranjan Maity; Jaiprakash Sharma; Parthanarayan Dey; Susarla K. Shankar; Parthasarathy Satishchandra; Nihar Ranjan Jana

Lafora disease (LD) is an autosomal recessive progressive myoclonic epilepsy characterized by the presence of intracellular polyglucosan inclusions commonly known as Lafora bodies in many tissues, including the brain, liver and skin. The disease is caused by mutations in either EPM2A gene, encoding the protein phosphatase, laforin, or EPM2B gene, encoding the ubiquitin ligase, malin. But how mutations in these two genes cause disease pathogenesis is poorly understood. In this study, we show that the Lafora bodies in the axillary skin and brain stain positively for the ubiquitin, the 20S proteasome and the molecular chaperones Hsp70/Hsc70. Interestingly, mutant malins that are misfolded also frequently colocalizes with Lafora bodies in the skin biopsy sample of the respective LD patient. The expression of disease-causing mutations of malin in Cos-7 cells results in the formation of the profuse cytoplasmic aggregates that colocalize with the Hsp70/Hsc70 chaperones and the 20S proteasome. The mutant malin expressing cells also exhibit proteasomal dysfunction and cell death. Overexpression of Hsp70 decreases the frequency of the mutant malin aggregation and protects from mutant malin-induced cell death. These findings suggest that Lafora bodies consist of abnormal proteins, including mutant malin, targeted by the chaperones or the proteasome for their refolding or clearance, and failure of these quality control systems could lead to LD pathogenesis. Our data also indicate that the Hsp70 chaperone could be a potential therapeutic target of LD.


Journal of NeuroVirology | 2003

Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: Is there a biological explanation?

S. K. Shankar; Parthasarathy Satishchandra; Anita Mahadevan; Tc Yasha; D Nagaraja; Ab Taly; S Prabhakar; Avindra Nath

Infection with human immunodeficiency virus (HIV) clade C virus is the most common form of HIV infection in the world. It largely infects populations in Africa and Asia and not much is known about the neurological complications associated with the virus. Cases of progressive multifocal leukoencephalopathy (PML) have been rarely reported in the literature in the acquired immunodeficiency syndrome (AIDS) or non-AIDS populations from these regions. In this article, the authors present three recently diagnosed patients with AIDS and PML from one neurological center in India, review the diagnostic challenges faced, and speculate on the possible biological reasons, including viral strain differences as well as HIV and JC virus interactions, that may account for the low incidence.

Collaboration


Dive into the Parthasarathy Satishchandra's collaboration.

Top Co-Authors

Avatar

Susarla K. Shankar

National Institute of Mental Health and Neurosciences

View shared research outputs
Top Co-Authors

Avatar

Anita Mahadevan

National Institute of Mental Health and Neurosciences

View shared research outputs
Top Co-Authors

Avatar

Sanjib Sinha

National Institute of Mental Health and Neurosciences

View shared research outputs
Top Co-Authors

Avatar

V. Ravi

National Institute of Mental Health and Neurosciences

View shared research outputs
Top Co-Authors

Avatar

Anita Desai

National Institute of Mental Health and Neurosciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D.K. Subbakrishna

National Institute of Mental Health and Neurosciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Udaykumar Ranga

Jawaharlal Nehru Centre for Advanced Scientific Research

View shared research outputs
Top Co-Authors

Avatar

Jitender Saini

National Institute of Mental Health and Neurosciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge